Hongkong and Shanghai Hotels Ltd (0045)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 22 Oct 2026
Key indicators
| Last close | HKD 5.130 |
|---|---|
| 52-week range | 4.860 – 7.260 |
| Return, 1 month / 3 months | −5.2% / −8.1% |
| Return, 1 year / 3 years | −14.5% / −15.2% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 27.4% |
| Worst drawdown (1 year) | -28.9% |
| Average daily value traded | 2.45M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hongkong and Shanghai Hotels owns and operates luxury hotels under The Peninsula brand, along with commercial properties and clubs. Its guests are mainly affluent travellers and business visitors, and its hotels sit in major cities across Asia, Europe and North America. The company also runs retail and office space alongside its hotel operations. It is based in Hong Kong, where its flagship hotel stands, and it manages a portfolio of properties in several countries.
On this site Hongkong and Shanghai Hotels Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 0045, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hongkong and Shanghai Hotels Ltd (0045) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 5.130 on 22 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 632 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.5% and over the last three months it fell 8.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -12.6% | ||
| From 52-week high | -26.7% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -8.1% | ||
| 6-month return | -15.2% | ||
| 12-month return, skipping the last month | -9.8% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.9% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.45M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.1% |
|---|---|
| 1 month | −5.2% |
| 3 months | −8.1% |
| 6 months | −15.2% |
| 1 year | −14.5% |
| 3 years | −15.2% |
| 5 years | −31.1% |
Signals
| 50-day / 200-day average | 5.387 / 5.868 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.174 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 May 2024 | HKD 0.0800 |
| 18 May 2020 | HKD 0.0900 |
| 29 Aug 2019 | HKD 0.0400 |
| 15 May 2019 | HKD 0.1600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.